Maxim E Annink
Overview
Explore the profile of Maxim E Annink including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Annink M, Kraaijenhof J, Beverloo C, Oostveen R, Verberne H, Stroes E, et al.
Eur Heart J Cardiovasc Imaging
. 2024 Dec;
26(3):444-460.
PMID: 39657321
Inflammation is an important driver of disease in the context of atherosclerosis, and several landmark trials have shown that targeting inflammatory pathways can reduce cardiovascular event rates. However, the high...
2.
Annink M, Boekholdt S, Stroes E
J Am Coll Cardiol
. 2024 Nov;
84(25):2442-2445.
PMID: 39545904
No abstract available.
3.
Reeskamp L, Annink M, Schonck W
JACC Adv
. 2024 Oct;
3(9):101181.
PMID: 39372471
No abstract available.
4.
Annink M, Janssen E, Reeskamp L
Curr Opin Lipidol
. 2024 Sep;
35(6):290-296.
PMID: 39259684
Purpose Of Review: Elevated lipoprotein(a) [Lp(a)] is a prevalent, independent, genetic risk factor for cardiovascular disease. Though crucial for adequate risk assessment, detection of individuals at increased risk because of...
5.
Annink M, Kraaijenhof J, Stroes E, Kroon J
Front Cell Dev Biol
. 2024 Aug;
12:1446758.
PMID: 39161593
Atherosclerotic cardiovascular disease (ASCVD) is the most important cause of morbidity and mortality worldwide. While it is traditionally attributed to lipid accumulation in the vascular endothelium, recent research has shown...